Scarica l'app Stockscreener
28.32
5.95%
1.61
Dopo l'orario di chiusura:
28.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$26.71
Aprire:
$26.73
Volume 24 ore:
197.48K
Relative Volume:
1.32
Capitalizzazione di mercato:
$549.47M
Reddito:
$138.20M
Utile/perdita netta:
$5.52M
Rapporto P/E:
74.53
EPS:
0.38
Flusso di cassa netto:
$9.86M
1 W Prestazione:
-4.46%
1M Prestazione:
-17.15%
6M Prestazione:
-28.10%
1 anno Prestazione:
-2.35%
Intervallo 1D:
$26.73
$28.70
Intervallo di 1 settimana:
$26.59
$30.42
Portata 52W:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Nome
Surmodics Inc
Settore
Industria
Telefono
(952) 500-7000
Indirizzo
9924 W 74TH ST, EDEN PRAIRIE, MN
Confronta SRDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
28.32 | 549.47M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
129.87 | 225.41B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.40 | 140.36B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.70B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.30B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.94 | 39.77B | 5.72B | 4.17B | 259.90M | 6.97 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Aggiornamento | Lake Street | Hold → Buy |
| 2023-06-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-02-13 | Downgrade | Needham | Buy → Hold |
| 2020-07-23 | Aggiornamento | Needham | Hold → Buy |
| 2019-12-11 | Downgrade | Needham | Buy → Hold |
| 2019-11-01 | Downgrade | Lake Street | Buy → Hold |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Lake Street | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-02-21 | Reiterato | Needham | Buy |
| 2018-05-16 | Reiterato | Needham | Buy |
| 2018-03-01 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-02-28 | Reiterato | Lake Street | Buy |
| 2018-02-28 | Iniziato | Needham | Buy |
| 2017-07-14 | Iniziato | Lake Street | Buy |
| 2016-11-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Downgrade | Sidoti | Buy → Neutral |
| 2016-05-03 | Reiterato | Barrington Research | Outperform |
| 2015-08-06 | Reiterato | Barrington Research | Outperform |
| 2015-03-27 | Iniziato | Dougherty & Company | Buy |
| 2014-02-25 | Iniziato | Laidlaw | Buy |
| 2013-08-01 | Aggiornamento | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Surmodics Inc Borsa (SRDX) Ultime notizie
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance
Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News
Lake Street Upgrades Surmodics (SRDX) - Nasdaq
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - MSN
Where are the Opportunities in (SRDX) - Stock Traders Daily
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private - Benzinga
FTC Sues to Block Sale of Surmodics - PlasticsToday
FTC targets GTCR in agency's first merger challenge under new Trump term - Crain's Chicago Business
FTC challenges private equity firm’s acquisition of Surmodics - Mass Device
FTC challenges $627M private equity takeover of Surmodics - MedTech Dive
Surmodics remains committed to GTCR merger despite US FTC suit - MLex
Why Surmodics Stock Is Falling On Friday - Benzinga
Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit - PE Hub
Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43 -March 07, 2025 at 08:46 am EST - Marketscreener.com
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal -March 07, 2025 at 04:39 am EST - Marketscreener.com
Rhumbline Advisers Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics contests FTC challenge to GTCR acquisition By Investing.com - Investing.com South Africa
Surmodics Responds To FTC Challenge, Commits To Completing Merger With GTCR - Nasdaq
US FTC sues to block private equity purchase of medical company - Reuters.com
Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR - Marketscreener.com
Surmodics contests FTC challenge to GTCR acquisition - Investing.com
Will FTC Block Surmodics' $627M Deal? Company Ready for Court Battle - StockTitan
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire
FTC Challenges PE Firm's Medical Device Coatings Deal - Law360
US FTC sues to block GTCR-Surmodics deal - MLex
FTC sues to block GTCR’s $627M Surmodics acquisition - Modern Healthcare
US FTC sues to block private equity buy of medical company -March 06, 2025 at 04:47 pm EST - Marketscreener.com
FTC Sues GTCR, Surmodics Over Medical Device Coatings Deal (1) - Bloomberg Law
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics - Marketscreener.com
GTCR-Surmodics merger challenged by US FTC - MLex
FTC sues to block acquisition of Surmodics - TipRanks
Surmodics drops after FTC files suit to block its planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Surmodics drops on report it will meet with regulators to try to save deal - MSN
Surmodics drops on report it will meet with regulators to try to save deal (SRDX:NASDAQ) - Seeking Alpha
SurModics: Fiscal Q3 Earnings Snapshot -July 31, 2024 at 07:17 am EDT - Marketscreener.com
Phocas Financial Corp. Cuts Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics Reports Successful Clinical Use of its Pounce XL Thrombectomy System - MPO-mag
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Olympiad Research LP - MarketBeat
How to Take Advantage of moves in (SRDX) - Stock Traders Daily
Zacks Research Has Bullish Outlook for Surmodics Q2 Earnings - Armenian Reporter
What is Zacks Research’s Estimate for Surmodics Q2 Earnings? - Defense World
Q3 Earnings Forecast for Surmodics Issued By Zacks Research - Defense World
Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
(SRDX) Technical Data - Stock Traders Daily
Surmodics shareholders approve key proposals at annual meeting - MSN
Surmodics shareholders approve key proposals at annual meeting By Investing.com - Investing.com Nigeria
Surmodics (NASDAQ:SRDX) Issues Quarterly Earnings Results - Armenian Reporter
Surmodics Q2 EPS Estimate Decreased by Barrington Research - MarketBeat
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Short Interest in Surmodics, Inc. (NASDAQ:SRDX) Increases By 33.0% - MarketBeat
Surmodics Inc Azioni (SRDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surmodics Inc Azioni (SRDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
3.50%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):